RL vs TRDA · P/E 24, rev $8.11B vs P/E 12, rev $210.8M
Ralph Lauren Corp Class A (RL) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
RL currently screens at market cap $16.95B and trailing P/E 24.1. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the RL and TRDA stock pages for the full models.
Not investment advice.